Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Valerie Vandersleyen actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Onderzoeksoutput
-
A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review
Kolivras, A., Thompson, C., Pastushenko, I., Mathieu, M., Bruderer, P., de Vicq, M., Feoli, F., Harag, S., Meiers, I., Olemans, C., Sass, U., Dehavay, F., Fakih, A., Lam-Hoai, X-L., Marneffe, A., Van De Borne, L., Vandersleyen, V. & Richert, B., jan 2022, In: Journal of cutaneous pathology. 49, 1, blz. 17-28 12 blz.Onderzoeksoutput: Book/Film/Article review
Open Access11 Citaten (Scopus) -
Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial
Schwarze, J. K., Garaud, S., Jansen, Y., Awada, G., Vandersleyen, V., Tijtgat, J., de Wind, A., Kristanto, P., Seremet, T., Willard-Gallo, K. & Neyns, B., feb 2022, In: Cancers (Basel). 14, 3, 22 blz., 682.Onderzoeksoutput: Article › peer review
Open AccessBestand2 Citaten (Scopus)11 Downloads (Pure) -
C-reactive protein as a biomarker for immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors in the adjuvant setting
Lauwyck, J., Beckwée, A., Santens, A., Schwarze, J. K., Awada, G., Vandersleyen, V., Aspeslagh, S. & Neyns, B., 1 aug 2021, In: Melanoma Research. 31, 4, blz. 371-377 7 blz.Onderzoeksoutput: Article › peer review
Open Access9 Citaten (Scopus) -
C-reactive protein as biomarker for immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors in the adjuvant setting
Lauwyck, J., Beckwee, A., Santens, A., Schwarze, J. K., Awada, G., Vandersleyen, V., Aspeslagh, S. & Neyns, B., sep 2020, In: Annals of Oncology. 31, blz. S759-S759Onderzoeksoutput: Meeting abstract (Journal)
-
A sequential dual cohort phase II clinical trial on adjuvant low-dose nivolumab with or without low-dose ipilimumab as adjuvant therapy following the resection of melanoma macrometastases (MM)
Schwarze, J. K., Vandersleyen, V., Awada, G., Seremet, T., Jansen, Y. & Neyns, B., 2019.Onderzoeksoutput: Poster
Activiteiten
-
Eurpean Society for Dermato-Oncology
Jolien Isabel Kessels (Participant) & Valerie Vandersleyen (Participant)
16 jan 2020 → 17 jan 2020Activiteit: Participation in conference
-
Cursus Ex vivo confocal microscopy
Gaëlle Leemans (Participant), Valerie Vandersleyen (Participant) & Michael Opsomer (Participant)
19 jun 2019 → 20 jun 2019Activiteit: Participation in workshop, seminar
-
Cours Dermatopathologie
Gaëlle Leemans (Participant) & Valerie Vandersleyen (Participant)
20 mei 2019 → 23 mei 2019Activiteit: Participation in workshop, seminar
-
Belgian Days of Dermatology
Michel Louisa Verheyden (Participant), Laura De Brucker (Participant), Emma Van Tendeloo (Participant), Annelies Anny Van Averbeke (Participant), Gitte Smets (Participant), Valerie Reynaert (Participant), Franciska Deviaene (Chair), Elise Georgette Vandersichel (Chair), Valerie Vandersleyen (Participant), Sara Hoang A Nguyen (Participant), Karlijn Clarysse (Participant) & Sanne Gielen (Participant)
14 feb 2019 → 16 feb 2019Activiteit: Participation in conference
-
Scientific retreat Dermatology department & SKIN research group
Michel Louisa Verheyden (Participant), Annelies Anny Van Averbeke (Participant), Valerie Vandersleyen (Participant), Isabelle Rooms (Participant), Sara Hoang A Nguyen (Participant), Gaëlle Leemans (Participant), Gitte Smets (Participant), Karlijn Clarysse (Participant), Eline Vandersteen (Chair), Emma Van Tendeloo (Participant) & Sofie De Schrijver (Participant)
25 okt 2019 → 26 okt 2019Activiteit: Participation in conference